267 related articles for article (PubMed ID: 31109867)
1. Bone metastasis: Interaction between cancer cells and bone microenvironment.
Hiraga T
J Oral Biosci; 2019 Jun; 61(2):95-98. PubMed ID: 31109867
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
Yoneda T; Hiraga T
Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
Futakuchi M; Fukamachi K; Suzui M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
[TBL] [Abstract][Full Text] [Related]
4. Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis.
Park SH; Keller ET; Shiozawa Y
Calcif Tissue Int; 2018 Feb; 102(2):152-162. PubMed ID: 29094177
[TBL] [Abstract][Full Text] [Related]
5. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
6. Examining the metastatic niche: targeting the microenvironment.
Guise T
Semin Oncol; 2010 Oct; 37 Suppl 2():S2-14. PubMed ID: 21111245
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles in Bone Metastasis: Key Players in the Tumor Microenvironment and Promising Therapeutic Targets.
Tamura T; Yoshioka Y; Sakamoto S; Ichikawa T; Ochiya T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932657
[TBL] [Abstract][Full Text] [Related]
8. Amino Acid Metabolism in Bone Metastatic Disease.
Edwards DN
Curr Osteoporos Rep; 2023 Aug; 21(4):344-353. PubMed ID: 37277592
[TBL] [Abstract][Full Text] [Related]
9. Bone Metastasis of Breast Cancer.
Tahara RK; Brewer TM; Theriault RL; Ueno NT
Adv Exp Med Biol; 2019; 1152():105-129. PubMed ID: 31456182
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
11. Role of the bone microenvironment in bone metastasis of malignant tumors - therapeutic implications.
Ma X; Yu J
Cell Oncol (Dordr); 2020 Oct; 43(5):751-761. PubMed ID: 32623700
[TBL] [Abstract][Full Text] [Related]
12. Insights into immuno-oncology drug development landscape with focus on bone metastasis.
Kähkönen TE; Halleen JM; MacRitchie G; Andersson RM; Bernoulli J
Front Immunol; 2023; 14():1121878. PubMed ID: 37475868
[TBL] [Abstract][Full Text] [Related]
13. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. New therapeutic targets for cancer bone metastasis.
Krzeszinski JY; Wan Y
Trends Pharmacol Sci; 2015 Jun; 36(6):360-73. PubMed ID: 25962679
[TBL] [Abstract][Full Text] [Related]
16. Animal model for mammary tumor growth in the bone microenvironment.
Futakuchi M; Singh RK
Breast Cancer; 2013 Jul; 20(3):195-203. PubMed ID: 23335063
[TBL] [Abstract][Full Text] [Related]
17. The origin of prostate metastases: emerging insights.
Santoni M; Piva F; Scarpelli M; Cheng L; Lopez-Beltran A; Massari F; Iacovelli R; Berardi R; Santini D; Montironi R
Cancer Metastasis Rev; 2015 Dec; 34(4):765-73. PubMed ID: 26363603
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of bone metastasis.
Mundy GR
Cancer; 1997 Oct; 80(8 Suppl):1546-56. PubMed ID: 9362421
[TBL] [Abstract][Full Text] [Related]
19. Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton.
Bogdanos J; Karamanolakis D; Tenta R; Tsintavis A; Milathianakis C; Mitsiades C; Koutsilieris M
Endocr Relat Cancer; 2003 Jun; 10(2):279-89. PubMed ID: 12790789
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic Microenvironment and Metastatic Bone Disease.
Hiraga T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]